Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001778623-26-000009

SVP, General Counsel and Sec. acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Veness Adam M SVP, General Counsel and Sec. 2026-08-13 Option exercise +15,000 $18.17 $272,550 15,000 D
Derivatives
Veness Adam M SVP, General Counsel and Sec. 2026-08-13 Option exercise · Stock Option (Right to Buy) −15,000 73,240 D
Loading xslF345X06/ownership.xml…